Dir
Eric K. Brandt is a seasoned corporate director and former technology and healthcare executive who serves as a director of Lam Research Corporation, where he has been on the board since September 2010.[[1]](https://newsroom.lamresearch.com/2010-09-10-Lam-Research-Corporation-Appoints-Eric-K-Brandt-to-Board-of-Directors)[[5]](https://www.nutanix.com/company/leadership/board-of-directors/eric-k-brandt)[[9]](https://www.lamresearch.com/company/company-overview/) At Lam Research, a leading semiconductor equipment company, Brandt contributes more than three decades of experience in finance, operations, and strategic transformation, drawing on senior roles across the semiconductor, pharmaceutical, and technology sectors.[[1]](https://newsroom.lamresearch.com/2010-09-10-Lam-Research-Corporation-Appoints-Eric-K-Brandt-to-Board-of-Directors)[[5]](https://www.nutanix.com/company/leadership/board-of-directors/eric-k-brandt) He currently also serves on the boards of Gen Digital Inc., Nutanix, Inc., and Option Care Health, Inc., and has previously served on the boards of Dentsply Sirona Inc., The Macerich Company, Yahoo! Inc., and others, frequently in audit, compensation, and governance leadership roles.[[2]](https://www.marketscreener.com/insider/ERIC-BRANDT-A02ETB/)[[4]](https://altaba.com/board-directors/eric-brandt/)[[5]](https://www.nutanix.com/company/leadership/board-of-directors/eric-k-brandt)[[6]](https://investors.optioncarehealth.com/board-member/eric-brandt)
Brandt’s executive career includes serving as Executive Vice President and Chief Financial Officer of Broadcom Corporation from 2007 until its acquisition by Avago in 2016, where he played a key role in scaling the semiconductor business through organic growth and acquisitions.[[1]](https://newsroom.lamresearch.com/2010-09-10-Lam-Research-Corporation-Appoints-Eric-K-Brandt-to-Board-of-Directors)[[4]](https://altaba.com/board-directors/eric-brandt/)[[5]](https://www.nutanix.com/company/leadership/board-of-directors/eric-k-brandt)[[6]](https://investors.optioncarehealth.com/board-member/eric-brandt) Before Broadcom, he was President and Chief Executive Officer of Avanir Pharmaceuticals, Inc., and earlier Executive Vice President–Finance and Technical Operations and Chief Financial Officer at Allergan Inc., following a decade as Vice President and Partner at The Boston Consulting Group.[[1]](https://newsroom.lamresearch.com/2010-09-10-Lam-Research-Corporation-Appoints-Eric-K-Brandt-to-Board-of-Directors)[[4]](https://altaba.com/board-directors/eric-brandt/)[[5]](https://www.nutanix.com/company/leadership/board-of-directors/eric-k-brandt)[[6]](https://investors.optioncarehealth.com/board-member/eric-brandt)[[8]](https://merage.uci.edu/_files/documents/events/2017/Eric-Brandt.pdf) Brandt holds a B.S. in Chemical Engineering from the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School.[[1]](https://newsroom.lamresearch.com/2010-09-10-Lam-Research-Corporation-Appoints-Eric-K-Brandt-to-Board-of-Directors)[[2]](https://www.marketscreener.com/insider/ERIC-BRANDT-A02ETB/)[[5]](https://www.nutanix.com/company/leadership/board-of-directors/eric-k-brandt)
View full insider profile →
Discussion